SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-003492
Filing Date
2020-03-13
Accepted
2020-03-12 17:34:02
Documents
15
Period of Report
2020-03-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cort-20200312.htm   iXBRL 8-K 44298
2 EX-99.1 exhibit991pressrelease.htm EX-99.1 8851
  Complete submission text file 0001628280-20-003492.txt   204906

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20200312.xsd EX-101.SCH 2599
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20200312_cal.xml EX-101.CAL 744
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20200312_def.xml EX-101.DEF 1708
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20200312_lab.xml EX-101.LAB 25478
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20200312_pre.xml EX-101.PRE 13281
11 EXTRACTED XBRL INSTANCE DOCUMENT cort-20200312_htm.xml XML 10997
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 20709936
SIC: 2834 Pharmaceutical Preparations